These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 30287265)

  • 1. Nano-targeted relaxin impairs fibrosis and tumor growth in pancreatic cancer and improves the efficacy of gemcitabine in vivo.
    Mardhian DF; Storm G; Bansal R; Prakash J
    J Control Release; 2018 Nov; 290():1-10. PubMed ID: 30287265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGF2 engineered SPIONs attenuate tumor stroma and potentiate the effect of chemotherapy in 3D heterospheroidal model of pancreatic tumor.
    Mardhian DF; Vrynas A; Storm G; Bansal R; Prakash J
    Nanotheranostics; 2020; 4(1):26-39. PubMed ID: 31911892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming tumor stroma using an endogenous lipid lipoxin A4 to treat pancreatic cancer.
    Schnittert J; Heinrich MA; Kuninty PR; Storm G; Prakash J
    Cancer Lett; 2018 Apr; 420():247-258. PubMed ID: 29408203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin α11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.
    Schnittert J; Bansal R; Mardhian DF; van Baarlen J; Östman A; Prakash J
    FASEB J; 2019 May; 33(5):6609-6621. PubMed ID: 30808244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxin prevents cardiac fibroblast-myofibroblast transition via notch-1-mediated inhibition of TGF-β/Smad3 signaling.
    Sassoli C; Chellini F; Pini A; Tani A; Nistri S; Nosi D; Zecchi-Orlandini S; Bani D; Formigli L
    PLoS One; 2013; 8(5):e63896. PubMed ID: 23704950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing PCBP2 normalizes desmoplastic stroma and improves the antitumor activity of chemotherapy in pancreatic cancer.
    Li Y; Zhao Z; Lin CY; Liu Y; Staveley-OCarroll KF; Li G; Cheng K
    Theranostics; 2021; 11(5):2182-2200. PubMed ID: 33500719
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer.
    Pothula SP; Xu Z; Goldstein D; Biankin AV; Pirola RC; Wilson JS; Apte MV
    Br J Cancer; 2016 Feb; 114(3):269-80. PubMed ID: 26766740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crosstalk Analysis between mPSCs and Panc1 Cells Identifies CCN1 as a Positive Regulator of Gemcitabine Sensitivity in Pancreatic Cancer Cells.
    Gündel B; Liu X; Pfützenreuter A; Engelsberger V; Weiskirchen R; Löhr JM; Heuchel R
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin in hepatic fibrosis: What is known and where to head?
    Ezhilarasan D
    Biochimie; 2021 Aug; 187():144-151. PubMed ID: 34102254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITGA5 inhibition in pancreatic stellate cells attenuates desmoplasia and potentiates efficacy of chemotherapy in pancreatic cancer.
    Kuninty PR; Bansal R; De Geus SWL; Mardhian DF; Schnittert J; van Baarlen J; Storm G; Bijlsma MF; van Laarhoven HW; Metselaar JM; Kuppen PJK; Vahrmeijer AL; Östman A; Sier CFM; Prakash J
    Sci Adv; 2019 Sep; 5(9):eaax2770. PubMed ID: 31517053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.
    Hesler RA; Huang JJ; Starr MD; Treboschi VM; Bernanke AG; Nixon AB; McCall SJ; White RR; Blobe GC
    Carcinogenesis; 2016 Nov; 37(11):1041-1051. PubMed ID: 27604902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
    Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
    Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
    Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-fibrotic actions of relaxin are mediated through AT
    Wang C; Pinar AA; Widdop RE; Hossain MA; Bathgate RAD; Denton KM; Kemp-Harper BK; Samuel CS
    FASEB J; 2020 Jun; 34(6):8217-8233. PubMed ID: 32297670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer-associated stromal fibroblasts promote pancreatic tumor progression.
    Hwang RF; Moore T; Arumugam T; Ramachandran V; Amos KD; Rivera A; Ji B; Evans DB; Logsdon CD
    Cancer Res; 2008 Feb; 68(3):918-26. PubMed ID: 18245495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells.
    Amrutkar M; Aasrum M; Verbeke CS; Gladhaug IP
    BMC Cancer; 2019 Jun; 19(1):596. PubMed ID: 31208372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming Growth Factor-β Limits Secretion of Lumican by Activated Stellate Cells within Primary Pancreatic Adenocarcinoma Tumors.
    Kang Y; Roife D; Lee Y; Lv H; Suzuki R; Ling J; Rios Perez MV; Li X; Dai B; Pratt M; Truty MJ; Chatterjee D; Wang H; Thomas RM; Wang Y; Koay EJ; Chiao PJ; Katz MH; Fleming JB
    Clin Cancer Res; 2016 Oct; 22(19):4934-4946. PubMed ID: 27126993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin-Induced Stromal Depletion to Enhance the Penetration of Gemcitabine-Loaded Magnetic Nanoparticles for Pancreatic Cancer Targeted Therapy.
    Han H; Hou Y; Chen X; Zhang P; Kang M; Jin Q; Ji J; Gao M
    J Am Chem Soc; 2020 Mar; 142(10):4944-4954. PubMed ID: 32069041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing Liposomes To Suppress Extracellular Matrix Expression To Enhance Drug Penetration and Pancreatic Tumor Therapy.
    Ji T; Lang J; Wang J; Cai R; Zhang Y; Qi F; Zhang L; Zhao X; Wu W; Hao J; Qin Z; Zhao Y; Nie G
    ACS Nano; 2017 Sep; 11(9):8668-8678. PubMed ID: 28806504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.
    Dalin S; Sullivan MR; Lau AN; Grauman-Boss B; Mueller HS; Kreidl E; Fenoglio S; Luengo A; Lees JA; Vander Heiden MG; Lauffenburger DA; Hemann MT
    Cancer Res; 2019 Nov; 79(22):5723-5733. PubMed ID: 31484670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.